Evidence map›Paper›PMID 35716138›Full record

ArticleInternational journal of cancer2022

Improving identification of symptomatic cancer at primary care clinics: A predictive modeling analysis in Botswana.

Kesaobaka Molebatsi, Hari S Iyer, Racquel E Kohler, Kemiso Gabegwe, Isaac Nkele, Bokang Rabasha, Kerapetse Botebele, Tomer Barak, Siamisang Balosang, Neo M Tapela and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Kesaobaka MolebatsiDepartment of Statistics, University of Botswana, Gaborone, Botswana.ORCID 0000-0002-9293-4470
Hari S IyerDepartment of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Racquel E KohlerDepartment of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA.
Kemiso GabegweBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Isaac NkeleBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Bokang RabashaBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Kerapetse BotebeleBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Tomer BarakBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Siamisang BalosangBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Neo M TapelaBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Scott L Dryden-PetersonBotswana-Harvard AIDS Institute Partnership, Gaborone, Botswana.
Botswana Harvard AIDS Institute Partnership · BWBeth Israel Deaconess Medical Center · USBrigham and Women's Hospital · USHarvard University · USRutgers, The State University of New Jersey · USUniversity of Botswana · BWUniversity of Oxford · GB

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Training Program in Cancer EpidemiologyT32CA009001 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI A. Heather Eliassen, Meir Stampfer · 1985 to 2026
$17.3M
Covid-19-related cervical cancer treatment interruption and role of neoadjuvant chemotherapyR01CA236546 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI DRYDEN-PETERSON, SCOTT · 2019 to 2023
$2.5M
NCI NIH HHS R01 CA236546NCI NIH HHS T32 CA009001NIAID NIH HHS P30 AI060354NIH HHS T32 CA 009001Wellcome TrustWellcome Trust 107752/Z/15/Z
6 · The paper itself

Abstract

In resource-limited settings, augmenting primary care provider (PCP)-based referrals with data-derived algorithms could direct scarce resources towards those patients most likely to have a cancer diagnosis and benefit from early treatment. Using data from Botswana, we compared accuracy of predictions of probable cancer using different approaches for identifying symptomatic cancer at primary clinics. We followed cancer suspects until they entered specialized care for cancer treatment (following pathologically confirmed diagnosis), exited from the study following noncancer diagnosis, or died. Routine symptom and demographic data included baseline cancer probability assessed by the primary care provider (low, intermediate, high), age, sex, performance status, baseline cancer probability by study physician, predominant symptom (lump, bleeding, pain or other) and HIV status. Logistic regression with 10-fold cross-validation was used to evaluate classification by different sets of predictors: (1) PCPs, (2) Algorithm-only, (3) External specialist physician review and (4) Primary clinician augmented by algorithm. Classification accuracy was assessed using c-statistics, sensitivity and specificity. Six hundred and twenty-three adult cancer suspects with complete data were retained, of whom 166 (27%) were diagnosed with cancer. Models using PCP augmented by algorithm (c-statistic: 77.2%, 95% CI: 73.4%, 81.0%) and external study physician assessment (77.6%, 95% CI: 73.6%, 81.7%) performed better than algorithm-only (74.9%, 95% CI: 71.0%, 78.9%) and PCP initial assessment (62.8%, 95% CI: 57.9%, 67.7%) in correctly classifying suspected cancer patients. Sensitivity and specificity statistics from models combining PCP classifications and routine data were comparable to physicians, suggesting that incorporating data-driven algorithms into referral systems could improve efficiency.

Indexed as

NeoplasmsAdultBotswanaHumansPrimary Health CareReferral and ConsultationSensitivity and Specificitypredictive modelingsymptomatic cancer

Identifiers

PMID35716138
PMCPMC10286759
OpenAlexW4283068342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.